Dual agonist

How much protein on tirzepatide (Mounjaro, Zepbound)

Tirzepatide (Mounjaro for type 2 diabetes labeling; Zepbound for obesity labeling in the US) is a dual GIP/GLP-1 receptor agonist. Appetite can fall hard. The 2025 joint advisory still discusses 1.2–1.6 g/kg protein during GLP-1–class weight loss, paired with resistance training. PivotOrder treats tirzepatide as the same protein job as semaglutide: print a working floor inside that band from weight, dose week, and appetite. Dual-agonist labeling can bump the working number inside the band — it does not invent a new medical threshold and does not guarantee preserved muscle. Lean share in SURMOUNT-1 DXA work has been reported near ~25% of lost weight in that analysis — literature, not your arms.

A small bowl of flaked salmon over a little rice

· Nutrition reference, not medical advice. Sources

Is the protein target different on tirzepatide vs Ozempic?

The published band is the same class of advice: roughly 1.2–1.6 g/kg during active weight reduction, with a clinician gram cap winning when one exists. Absolute grams matter more than protein as a percent of shrinking calories.

What differs in the product is a labeled dual-agonist increment that still clamps into the band. That is a start rule for the card, not a claim that tirzepatide requires a different society guideline.

What did SURMOUNT-1 body-composition work actually report?

Look and colleagues reported DXA body-composition changes on tirzepatide in SURMOUNT-1 (Diabetes Obes Metab, 2025), with lean share near about a quarter of lost weight in that analysis. Linge and colleagues (Circulation, 2024) reviewed muscle and GLP-1 receptor agonists more broadly.

We cite those papers. We did not run them. We do not translate a trial mean into your grip strength.

Tirzepatide on the card — labeled as product rules
InputWhat the card doesWhat it refuses
Drug = tirzepatideApplies dual-agonist bump inside 1.2–1.6 g/kgA personal DXA forecast
Dose weekMoves the working floor with the week on drugA shot log or titration advice
Appetite / volumeHarder weeks get a plate job you can keep downA nausea prescription
Leucine ~2.7 g workingScores three hits against this week’s thresholdA powder checkout

What should I do this week on Mounjaro or Zepbound?

Enter weight and week on drug. Print the floor. Hit three leucine-checked plates or sips. Lift if your clinician says you can. Recast when dose-week, appetite, or weight move. Do not change the pen from an app.

Questions people ask

How much protein should I eat on Mounjaro or Zepbound?
Use a clinician number if you have one. Otherwise the 2025 advisory discusses 1.2–1.6 g/kg during weight loss. PivotOrder prints a working floor inside that band for tirzepatide weeks.
Does tirzepatide spare more muscle than semaglutide?
This product does not answer that. Both can quiet appetite. Both can include lean tissue in published weight-loss composition work. Protein plus training remains the pairing we operationalize.
Is Zepbound different from Mounjaro for the protein floor?
Same molecule class for the card’s appetite job. Labeling and indication differ clinically; the protein floor still sits inside the published band from the weight and week you enter.